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INTRODUCTION
The prevalence of ascending aorta aneurysm in the general 
population is reported to be 0.3–0.4%.1 Several observational 
studies have demonstrated that if this condition is left untreat-
ed it may lead to fatal aortic dissection or rupture.2-4
Indications for ascending aorta replacement surgery are 
based on aortic diameter and historical data on the risk of com-
plications of elective surgery. Surgery should be performed 
for Marfan syndrome and a maximal aortic diameter ≥50 mm. 
A lower threshold of 45 mm can be considered in patients pre-
senting with a positive family history, hypertension, coarcta-
tion, or an annual increase of more than 3 mm. Managing tho-
racic aortic aneurysm in patients with bicuspid aortic valve 
has been very controversial. European Society of Cardiology 
guidelines recommend that surgery should be performed in 
patients with a bicuspid aortic valve with a maximal diameter 
≥55 mm.5,6 Meanwhile, however, Norton and Yang7 have em-
phasized the importance of aortic root phenotype in bicuspid 
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aortic valve and have suggested that diameters of the root ex-
ceeding 45 mm should be indications for surgery.
The management of a moderately dilated ascending aorta 
remains controversial. For patients with one of the above indi-
cations for surgery, a lower aortic diameter threshold of >45 
mm may be applied for aortic valve replacement (AVR), de-
pending on age, body size, etiology of valvular disease, and in-
traoperative shape and thickness of the ascending aorta. How-
ever, these guidelines are not appropriate for all patients with 
dilated ascending aorta undergoing AVR surgery (e.g., patients 
at high risk for stroke). In such patients, a less aggressive ap-
proach of ascending aortic wrapping during AVR may be se-
lected to reduce the cardiopulmonary bypass time and mini-
mize the risk of circulatory arrest. 
External wrapping is a simple technique that involves short-
er pump and cardiac ischemia times than ascending aorta re-
placement, as well as reduced hypothermia, which may result 
in improved short-term outcomes. However, the long-term re-
sults of this method compared with replacement of the as-
cending aorta are unclear. Furthermore, there is significant 
concern that intrinsic aortic wall abnormalities present in an-
eurysm patients may persist after aortic wrapping, and there-
fore, these patients may remain at higher risk of developing si-
nus of Valsalva or arch aneurysms.8-10 The aim of the present 
study was to investigate the long-term outcomes of aortic an-
eurysms in patients who underwent aortic wrapping, with a 
particular focus on identifying predictors of aortic redilation, 
depending on the region of three different levels. 
MATERIALS AND METHODS
Ethics statement
This study was conducted in accordance with the principles 
embodied in the Declaration of Helsinki and was approved by 
the Institutional Review Board of Severance Hospital, Republic 
of Korea (IRB number: 2018-1593-001). The requirement for 
acquisition of informed consent from individual patients was 
waived owing to the retrospective nature of this study. 
Patients 
A total of 1050 patients underwent AVR for aortic stenosis or re-
gurgitation between 1995 and 2015 at our institution. Of these, 
301 consecutive patients presented with ascending aortic dil-
atation of 40–55 mm. Wrapping of the ascending aorta during 
AVR was carried out for 96 patients, and these patients were 
included in the present study. The decision to perform con-
comitant aortic procedures was influenced by aortic size, mor-
phology of the aortic valve, and expected surgical risks of com-
plications affecting left ventricular function. The final decision 
was at the discretion of the attending surgeon.
Exclusion criteria were as follows: 1) patients with defined 
congenital anomalies, 2) patients who underwent aortic valve 
repair instead of replacement, 3) patients with a history of car-
diac surgery, 4) patients who underwent concomitant proce-
dures on other valves (mitral or tricuspid) because of the pos-
sible effect on hemodynamic performance, and 5) patients 
with acute dissecting aortic aneurysms. 
Perioperative data including echocardiographic reports, 
heart computed tomography (CT) imaging, and all operative 
records were collected from the database and through retro-
spective review of medical records. Aortic measurements are 
made using the true short axis projection acquired from dou-
ble oblique views, from one blood-wall boundary to another. 
The aortic diameter was measured at the level of the sinuses 
of Valsalva, the sinotubular (ST) junction, the mid-ascending 
aorta, and the proximal arch. Interpretations of CT examina-
tions were provided by a cardiothoracic radiology specialist 
with >10-year experience in evaluating various image modali-
ties. During echocardiographic assessments, the size of the 
ascending aorta was routinely measured in the parasternal long 
axis view. 
Surgical technique
Aortic wrapping was performed after the completion of hemo-
stasis and protamine reversal following AVR. Polytetrafluoro-
ethylene (PTFE) or double-velour vascular grafts were used to 
surround the native ascending aorta (Fig. 1). Materials for wrap-
ping were chosen according to the surgeons’ preferences. Three 
surgeons participated in this study and used a common tech-
nique to ensure consistency in the tightness of the wrap. The 
length of the vascular graft was determined according to the 
distance along the greater curvature between the ST junction 
and the origin of the innominate artery. Once the native aorta 
was surrounded by the graft, the graft was attached by contin-
uous suturing with 4-0 or 3-0 polypropylene (Ethicon Inc., 
Somerville, NJ, USA). To prevent graft migration, several inter-
rupted 3-0 polypropylene mattress sutures (Ethicon Inc.) were 
used to anchor the proximal and distal parts of the graft to the 
aorta.
Endpoints and data collection
The primary endpoints were all-cause death and adverse aor-
tic events, including aortic dissection, rupture, reoperation, 
and sudden death. Data were obtained through regular visits 
to the outpatient clinic. Early mortality was defined as death 
within 30 days of surgery. 
The secondary endpoint was diameter change of the aorta 
during follow-up. To assess changes in maximal diameter at 
individual aortic levels in patients who underwent AVR with 
wrapping, serial postoperative echocardiographic and CT data 
were reviewed. Generally, follow-up echocardiographic eval-
uations were performed at 6 months, 12 months, and yearly 
thereafter. 
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Statistical analysis 
Simple descriptive statistics were used to summarize the data. 
Continuous variables are presented as mean±standard devia-
tion. Categorical data are described using frequencies and 
percentages. 
A paired t-test was performed to compare maximal aortic 
diameter measured immediately after surgery with the final 
follow-up measurement. Subgroup analysis using a linear 
mixed-effects model (LMM) was performed to analyze the 
overall outcomes of aortic diameter for the 96 patients who 
underwent more than two postoperative imaging studies. The 
following variables were included in the univariable model: 
age, sex, body surface area, presence of bicuspid aortic valve 
or hypertension, wrapping material (either PTFE or not), and 
initial ascending aortic diameter. A total of three variables were 
included in the multivariable model, with a significance level 
of 0.10. To determine the best threshold for aortic diameter 
with redilation as a confounding factor, receiver operating char-
acteristic (ROC) curve analysis was performed. 
The Kaplan-Meier method was used to generate survival 
curves and calculate 5- and 10-year survival statistics and free-
dom from significant redilation. The IBM SPSS Statistics pack-
age (version 23.0, IBM-SPSS Inc., Armonk, NY, USA) was used 
for all statistical analyses.
RESULTS
The mean age at the time of surgery was 62.3±8.5 years. Pa-
tients were predominately male (61.5%); 56.3% had bicuspid 
aortic valves; and 43.8% had hypertension. The dominant func-
tional valvular disease was aortic stenosis for 70% of patients 
and regurgitation for 30% of patients. The mean preoperative 
mid-ascending aortic diameter was 43.0±5.7 mm (Table 1). 
Fig. 1. Illustration of aortic wrapping carried out with (A) polytetrafluoro-
ethylene felt and (B) double-velour vascular grafts.
A
B
Table 1. Baseline Characteristics and Procedure-Related Details
Variable Values (n=96)
Mean age (yr) 62.3±8.5
Male 59 (61.5)





Aortic stenosis 67 (70.0) 
Aortic regurgitation 29 (30.0)
Mixed ASR 41 (42.7) 
Maximal aortic diameter (mm) [mean±standard deviation (range)]
Aortic annulus 21.1±4.7 (16.0–26.7)
Sinus of Valsalva 37.6±7.3 (21.2–40.9)
Sinotubular junction 31.9±6.8 (19.3–39.6)
Mid-ascending aorta 43.0±5.7 (40.0–53.8) 
Proximal aortic arch 37.0±7.7 (28.0–50.1)
Marfan syndrome 2 (2.1)
Hypertension 42 (43.8)
Diabetes mellitus 18 (18.8)
Chronic obstructive pulmonary disease 4 (4.2)
Chronic kidney disease 3 (3.1)
Peripheral arterial occlusive disease 1 (1.0)
Previous cerebrovascular accident 4 (4.2)
NYHA functional class 2.7±0.6
Wrapping material 
PTFE felt 58 (60.4)
Double-velour 38 (39.6)
Prosthetic valve type 
Mechanical 58 (60.4)
Biological 38 (39.6)
Concomitant CABG surgery 7 (7.3)
ACC time (min)  83.0±26.6
CPB time (min) 115.4±34.3
BSA, body surface area; ASR, aortic stenosis and regurgitation; NYHA, New 
York Heart Association; PTFE, polytetrafluoroethylene; CABG, coronary artery by-
pass graft surgery; ACC, aortic cross-clamping; CPB, cardiopulmonary bypass.
Values are expressed as mean±standard deviation for continuous data or n 
(%) for categorical data unless otherwise indicated.
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Operative data 
As shown in Table 1, [Teflon® (DuPont Pharmaceuticals, 
Wilmington, DE, USA) or Dacron® (DuPont Pharmaceuticals, 
Wilmington, DE, USA) felt] was used to surround the native 
ascending aorta in 60.4% of patients. Double-velour vascular 
grafts [Hemashield® (Meadox Medicals, Oakland, NJ, USA) 
or Intergard® (InterVascular, La Ciotat, France)] were used in 
39.6% of patients. There were no uniform institutional policies 
with respect to the procedures performed. Mechanical pros-
theses were used in more cases (60.4%) than biological pros-
theses (39.6%), and the mean size of prosthetic aortic valve 
was 22.2±1.8 mm. The mean aortic cross-clamping time was 
83.0±26.6 min, and the mean cardiopulmonary bypass time was 
115.4±34.3 min.
Early outcomes 
Operative mortality was zero. Two patients underwent reop-
eration for bleeding (2.1%). Postoperative percutaneous car-
diopulmonary support was required for two patients (2.1%) 
due to low cardiac output syndrome, and four patients (4.2%) 
required pacemaker insertion due to complete AV block. Four 
patients (4.2%) had transient ischemic attacks, whereas three 
patients (3.1%) had permanent stroke. One patient (1.0%) re-
quired reintubation due to pneumonia. Table 2 summarizes 
the perioperative details.
Changes in aortic diameter 
As Table 3 shows, the paired t-test revealed significant differ-
ences between aortic diameter measurements immediately 
after surgery and at the final follow-up (as assessed by CT/
echocardiographic analysis) at the level of the proximal aortic 
arch only (p=0.050). Furthermore, subgroup analysis using 
Table 2. Operative Outcomes Measured Over the Follow-Up Duration 
(n=96)
Variable Values
In-hospital mortality 0 (0)
In-hospital complications 
Re-operation for mediastinal bleeding 2 (2.1)
Low cardiac output syndrome 2 (2.1)
Complete atrioventricular block 4 (4.2)
Neurologic deficit 4 (4.2) 
Respiratory failure 1 (1.0)
Wound problem 1 (1.0)
Gastrointestinal tract bleeding 5 (5.2)
All values represent categorical data and are expressed as n (%).
Table 3. Comparison of Maximal Cross-Sectional Aortic Diameter Immediately after Surgery with Diameter at Final Follow Up (CT/Echocardiographic 
measurements) (n=96)
Measurement of aortic diameter (mm) 
p value
Immediately after surgery At median follow up At final follow up
Sinuses of Valsalva 37.6±7.3 37.8±7.4 38.1±6.2 0.300
Sinotubular junction 31.3±6.3 31.9±6.9 32.7±7.1 0.523
Mid-ascending aorta 37.0±7.7 37.0±7.9 37.1±7.4 0.823
Proximal aortic arch 37.0±7.9 37.1±8.2 38.8±7.3 0.050
Data are expressed as mean±standard deviation, and p values were calculated by paired t-tests to compare immediate postoperative measurements with those 
at the final follow up.
Fig. 2. Spaghetti plot of aortic growth rate over time after aortic wrapping 
for individual patients. Aortic diameters were measured at the level of (A) 
the aortic root, (B) the ascending aorta, and (C) the proximal arch. Red lines 
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LMM indicated that the diameter at this aortic arch level in-
creased over time (p=0.006, Fig. 2).
Sinus of Valsalva
The size of the sinuses of Valsalva maintained stable growth 
rates of 0.069 mm/year (p=0.524) (Fig. 2). Significant redilation 
of the sinus of Valsalva was observed for two patients (2.1%). 
The initial aortic annulus size (p<0.001) and presence of bicus-
pid aortic valve (p=0.013) were associated with an increase in 
the size of sinus of Valsalva. However, LMM analysis indicated 
that these factors did not affect the growth rate over time.
Ascending aorta
Five patients (5.2%) had redilation of the ascending aorta. In 
these patients, an increase in ascending aorta size of 0.152 
mm/year was observed, although this was not statistically sig-
nificant (p=0.124). The initial sizes of the ST junction and 
proximal arch significantly influenced the growth rate of the 
ascending aorta (p=0.021 and p=0.045, respectively). When 
expressed as change in diameter versus time (Fig. 2), no rela-
tionship was apparent. 
Aortic arch 
The maximum diameter of the proximal aortic arch increased 
at a rate of 0.343 mm/year (Fig. 2). Significant redilation of the 
proximal arch was observed in eight patients (8.3%) (p=0.006). 
Subgroup analysis of aortic arch diameter increases indicated 
that there was no significant influence from male sex, body sur-
face area, presence of bicuspid aortic valve, or presence of hy-
pertension on the rate of increase (p=0.183, 0.785, 0.171, and 
0.855, respectively). However, age, initial ascending aortic di-
ameter, and the use of PTFE wrapping material had significant 
effects on the rate of aortic arch dilatation (p=0.048, 0.079, and 
0.001, respectively) in the univariable models (Table 4).
Predictors of aortic arch growth were assessed by multivari-
able LMM. This revealed that initial ascending aortic diameter 
(p=0.032) and the use of PTFE felt wrapping material (p=0.008) 
were independent risk factors for increased aortic arch diam-
eter (Table 4). 
In the ROC curve showing the diagnostic performance of 
the ascending aorta diameter for re-dilation, and its area un-
der the curve was 0.747, with a 90% confidence interval of 
0.613–0.881 (p=0.023) (Fig. 3). An ascending aorta diameter of 
46.95 mm could be regarded as the optimal cut-off value for 
predicted re-dilation of the proximal arch. Overall, freedom 
from redilation of the proximal aortic arch was 100% and 97.9% 
after 5 and 10 years, respectively (Fig. 4).
Late outcomes 
The maximum follow-up time was 19.5 years, with a median 
of 9.1 years (mean 8.7±2.1 years). The rate of echocardiogram 
or CT follow-up was 95.9%. The mean interval period between 
initial and final follow-up was 7.2±4.6 years. During the follow-
up period, aortic root rupture occurred in one patient who un-
derwent aortic wrapping. One patient required aorta-related 
re-operation (total arch replacement) due to proximal arch dil-
atation, and transcatheter aortic valve implantation was per-
formed to correct aortic valve dysfunction in one patient at 13 
years after AVR surgery. 
A total of nine patients (9.4%) died during follow-up, with 
known cardiac causes in two cases (2.1%). One 53-year-old fe-
male patient underwent wrapping, as well as AVR with a me-
chanical valve. A PTFE felt graft had been used. In this case, re-
dilation occurred 7.8 months after surgery, which developed 
Table 4. Subgroup Analysis of Aortic Arch Diameter Expansion (mm/
month) Using a Univariable and Multivariable Linear Mixed Model
B±standard error p value
Univariable linear mixed model
Age (yr) 0.002±0.001 0.048
Male -0.027±0.020 0.183
BSA 0.017±0.063 0.785
Initial ascending aortic diameter (mm) 0.003±0.001 0.079
Presence of bicuspid 0.027±0.019 0.171
Use of PTFE felt or not -0.067±0.020 0.001
Presence of hypertension 0.004±0.019 0.855
Multivariable linear mixed model
Age (yr) 0.002±0.001 0.190
Initial ascending aortic diameter (mm) 0.003±0.001 0.032
Use of PTFE felt or not -0.057±0.021 0.008
BSA, body surface area; PTFE, polytetrafluoroethylene.
p values were calculated from the interaction between variables at a time of 
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Fig. 3. Receiver-operating characteristic curve analysis of initial ascend-
ing aortic diameter affecting redilation of the proximal aortic arch after 
wrapping. AUC, area under the curve; CI, confidence interval.
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to aortic root rupture at 7.1 years after surgery. The patient died 
due to hypovolemic shock caused by mediastinal bleeding. 
Another patient, a 50-year-old female with underlying lung 
cancer, died from heart failure due to atrioventricular node 
dysfunction. During follow-up, the causes of non-cardiac death 
were as follows: gastrointestinal bleeding in one patient (1.0%), 
sepsis in two patients (2.1%), and metastatic cancer in four pa-
tients (4.2%). Overall survival is illustrated in Fig. 4. 
DISCUSSION
In the present study, we found the occurrence of adverse aortic 
events during long-term follow-up to be rare (2.1%) following 
ascending aorta wrapping during AVR. The standard treatment 
for dilated ascending aorta is ascending aorta replacement; 
nonetheless, surgeons may consider a less invasive alternative 
of aortic wrapping or no aortic procedure for high-risk patients.
Our results demonstrate that aortic wrapping results in de-
creased ascending aortic diameter with long-term stability. 
Over time, dilation of both the ST junction and mid-ascending 
aorta did increase, although the changes were not statistically 
significant (p=0.524 and 0.124, respectively). The rate of reop-
eration of the aorta was therefore very low (2.1%). These results 
agree with the meta-analysis performed by Plonek11, which 
reported that significant dilatation of any aortic segment was 
only observed during follow-up of 12 (1.7%) of the 722 patients 
and that only 13 (1.8%) required reoperation or reintervention 
for residual or recurrent aortic pathologies.12,13
Ascending aortic wrapping contributed to stabilization of 
the aortic root with excellent long-term durability, consistent 
with earlier studies from another institution.14-16 Zhang, et al.17 
reported that aortic root dilation was slightly increased after 
replacement, compared with that observed following aortic 
wrapping. Redilation occurred in areas which were not rein-
forced or where reinforcement was insufficient, most notably 
in the noncoronary sinus of Valsalva. In one patient of the pres-
ent study, significant redilation was observed in the proximal 
areas of wrapping, including the sinus of Valsalva (p=0.524). 
Plonek’s systematic review supports these results, as the au-
thors found no aortic root enlargement when the external pros-
thesis was secured by proximal and distal fixation.11
However, aortic wrapping led to a significant increase in the 
rate of enlargement of the proximal arch (0.343 mm/year, p= 
0.006). Failure to stabilize the proximal arch may lead to the 
risk of dilation over time, potentially requiring additional sur-
gery. This risk is particularly high in young patients with a long 
life expectancy. For this reason, most surgeons prefer to per-
form ascending aortic wrapping in patients who are over 70 
years old or who have a limited life expectancy.14 The enlarge-
ment may result from different hemodynamic stresses placed 
on the proximal arch by the aortic root or ascending aorta. He-
modynamic turbulence is the most common cause of aortic 
dilation, and aortic valve disease and intrinsic aortopathy are 
major causes of hemodynamic stress.18 Thus, the present study 
demonstrates that further expansion at the proximal arch lev-
el after correction of the aortic valve may be attributable to in-
trinsic aortopathy. 
We found initial ascending aortic diameter to be a signifi-
cant risk factor for aortic arch dilatation by multivariable LMM 
analysis. These results imply that native aneurysmal size is an 
important index for surgical therapy. Thus, the cut-off value of 
47 mm in this study reinforced the current size-based guide-
lines, in that moderate dilation of the ascending aorta (>45 
mm) is a risk factor for redilation. 
The wrapping material that is used for ascending aortic 
wrapping is an important consideration for surgeons. During 
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Fig. 4. Freedom from redilation of the proximal aortic arch and overall survival after wrapping by Kaplan-Meier analysis.
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in 58 patients with PTFE felt and in 38 patients with double-
velour vascular grafts. Proximal aortic expansion was signifi-
cantly correlated with the use of PTFE felt (p=0.008). This result 
is supported by a study by Randall, et al.,19 who reported a study 
in which joined carotid arteries were anastomosed to PTFE or 
double-velour grafts in a canine model. The PTFE grafts showed 
increased calcification and intimal fibrin deposition micro-
scopically. Therefore, we suggest that double-velour grafts have 
more acceptable outcomes for wrapping in terms of stabiliza-
tion of the aorta. 
In subgroup analysis, bicuspid aortic valve (n=54, 56.3%) 
was not found to affect the aortic arch diameter. Although this 
aortopathy is well known to influence the incidence of aneu-
rysm, it was not found to be a risk factor for aortic redilation 
after wrapping. In line with this result, the guidelines for repair 
of bicuspid aortic valve-associated ascending thoracic aortic 
aneurysms have recently been changed to use the same crite-
ria as for repair of tricuspid aortic valve-associated ascending 
thoracic aortic aneurysms.20
The present study has several limitations. Firstly, the study 
population did not include a control group. Secondly, this 
study was a retrospective analysis of observational data. Third-
ly, procedures were selected by the surgeons, and 12 patients 
with aortic diameters of less than 4.5 cm underwent aortic 
wrapping owing to aortic wall enforcement. Recent changes in 
the guidelines with respect to American College of Cardiolo-
gy/American Heart Association (AHA) criteria currently spec-
ify that the indication for ascending aortic aneurysm associat-
ed with bicuspid valve is 5.5 cm. Therefore, this study may differ 
from current recommendations. Lastly, there was a lack of 
quantitative data concerning the phenotype of the ascending 
aorta, such as fusiform or saccular aneurysms. Not all patients 
were able to be assessed with CT at the final follow-up. Some 
aortic size measurements were carried out using transthorac-
ic echocardiographic assessment, which is not the gold stan-
dard method for aortic evaluation. The limited modality of 
echocardiographic and CT follow-up is therefore an impor-
tant limitation of this study. 
The number of mortalities or patients with redilation was 
too small to evaluate the surgical risks with appropriate statis-
tical power. Therefore, the safety and durability of aortic wrap-
ping should be addressed in further studies using larger pop-
ulations over longer durations.
Aortic wrapping led to stabilization of the dilated aorta, with 
excellent long-term durability. In this study, the diameter of the 
proximal arch increased over time in patients with an ascend-
ing aortic diameter of over 47 mm. Therefore, the results of this 
study suggest that redilation of the proximal arch should be 
carefully observed during long-term follow-up after aortic wrap-
ping surgery. Further large-scale prospective trials are required 
to define appropriate indications for concomitant aorta wrap-
ping during AVR.
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